

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * tricarboxylic acid cycle (GO:0006099) | 7.47583213 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.01750102 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.96862957 |
| 4 | * NADH metabolic process (GO:0006734) | 5.91652961 |
| 5 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.84981556 |
| 6 | succinate metabolic process (GO:0006105) | 5.67986576 |
| 7 | regulation of cofactor metabolic process (GO:0051193) | 5.49403332 |
| 8 | regulation of coenzyme metabolic process (GO:0051196) | 5.49403332 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 5.46432282 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.46432282 |
| 11 | respiratory electron transport chain (GO:0022904) | 5.39178219 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.34465807 |
| 13 | electron transport chain (GO:0022900) | 5.25900755 |
| 14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.20295289 |
| 15 | oxaloacetate metabolic process (GO:0006107) | 5.19066832 |
| 16 | oxidative phosphorylation (GO:0006119) | 5.05550780 |
| 17 | lysine metabolic process (GO:0006553) | 5.02455104 |
| 18 | lysine catabolic process (GO:0006554) | 5.02455104 |
| 19 | ribosomal small subunit biogenesis (GO:0042274) | 5.01596068 |
| 20 | carnitine shuttle (GO:0006853) | 4.96618337 |
| 21 | regulation of mitochondrial translation (GO:0070129) | 4.64279541 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.56082012 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 4.56012962 |
| 24 | aspartate family amino acid catabolic process (GO:0009068) | 4.47998988 |
| 25 | * 2-oxoglutarate metabolic process (GO:0006103) | 4.45852193 |
| 26 | regulation of sulfur metabolic process (GO:0042762) | 4.45847067 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 4.42805675 |
| 28 | proteasome assembly (GO:0043248) | 4.31157497 |
| 29 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.30238379 |
| 30 | sarcomere organization (GO:0045214) | 4.28858877 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 4.26628410 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.24331922 |
| 33 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.12777741 |
| 34 | branched-chain amino acid catabolic process (GO:0009083) | 4.07456221 |
| 35 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.03793019 |
| 36 | establishment of integrated proviral latency (GO:0075713) | 4.02458378 |
| 37 | regulation of sequestering of triglyceride (GO:0010889) | 3.99082768 |
| 38 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.94590386 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.90455948 |
| 40 | negative regulation of ligase activity (GO:0051352) | 3.90455948 |
| 41 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.88657165 |
| 42 | protein maturation by protein folding (GO:0022417) | 3.87855757 |
| 43 | regulation of fatty acid oxidation (GO:0046320) | 3.86363359 |
| 44 | cardiac myofibril assembly (GO:0055003) | 3.86316794 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.86207908 |
| 46 | DNA strand elongation (GO:0022616) | 3.86085363 |
| 47 | formation of translation preinitiation complex (GO:0001731) | 3.86020284 |
| 48 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.85032344 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.83978425 |
| 50 | cardiac muscle contraction (GO:0060048) | 3.83158066 |
| 51 | carnitine transmembrane transport (GO:1902603) | 3.82163839 |
| 52 | fatty acid catabolic process (GO:0009062) | 3.81906959 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.81691285 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.74853078 |
| 55 | ATP biosynthetic process (GO:0006754) | 3.73125559 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 3.73006134 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.72135860 |
| 58 | acetyl-CoA metabolic process (GO:0006084) | 3.71781261 |
| 59 | carnitine transport (GO:0015879) | 3.71519332 |
| 60 | amino-acid betaine transport (GO:0015838) | 3.71519332 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.71095812 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.69615598 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.69615598 |
| 64 | muscle filament sliding (GO:0030049) | 3.69506609 |
| 65 | actin-myosin filament sliding (GO:0033275) | 3.69506609 |
| 66 | fatty acid oxidation (GO:0019395) | 3.69136830 |
| 67 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.68780976 |
| 68 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.68747291 |
| 69 | short-chain fatty acid metabolic process (GO:0046459) | 3.68094591 |
| 70 | regulation of relaxation of muscle (GO:1901077) | 3.65860240 |
| 71 | regulation of cell communication by electrical coupling (GO:0010649) | 3.64936062 |
| 72 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.64814851 |
| 73 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.64814851 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.64814851 |
| 75 | maturation of SSU-rRNA (GO:0030490) | 3.63437436 |
| 76 | lipid oxidation (GO:0034440) | 3.63083665 |
| 77 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.60567484 |
| 78 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.60567484 |
| 79 | inner mitochondrial membrane organization (GO:0007007) | 3.59867338 |
| 80 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.56825548 |
| 81 | * tricarboxylic acid metabolic process (GO:0072350) | 3.56647470 |
| 82 | establishment of viral latency (GO:0019043) | 3.56454466 |
| 83 | myofibril assembly (GO:0030239) | 3.56401929 |
| 84 | ribosomal large subunit biogenesis (GO:0042273) | 3.56307185 |
| 85 | valine metabolic process (GO:0006573) | 3.54729799 |
| 86 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.51129552 |
| 87 | regulation of oxidative phosphorylation (GO:0002082) | 3.50495682 |
| 88 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.47372095 |
| 89 | quinone biosynthetic process (GO:1901663) | 3.44244124 |
| 90 | ubiquinone biosynthetic process (GO:0006744) | 3.44244124 |
| 91 | protein targeting to mitochondrion (GO:0006626) | 3.43176499 |
| 92 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.42974137 |
| 93 | ncRNA 3-end processing (GO:0043628) | 3.41659248 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.38831200 |
| 95 | gluconeogenesis (GO:0006094) | 3.37771356 |
| 96 | regulation of actin filament-based movement (GO:1903115) | 3.37747104 |
| 97 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.37223998 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 3.35682594 |
| 99 | biotin metabolic process (GO:0006768) | 3.33958122 |
| 100 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.33834917 |
| 101 | aerobic respiration (GO:0009060) | 3.33726066 |
| 102 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.30184989 |
| 103 | viral transcription (GO:0019083) | 3.26497856 |
| 104 | ketone body metabolic process (GO:1902224) | 3.26459880 |
| 105 | positive regulation of ligase activity (GO:0051351) | 3.26089162 |
| 106 | carnitine metabolic process (GO:0009437) | 3.26062020 |
| 107 | regulation of translational fidelity (GO:0006450) | 3.22928429 |
| 108 | hexose biosynthetic process (GO:0019319) | 3.19339955 |
| 109 | regulation of skeletal muscle contraction (GO:0014819) | 3.18059574 |
| 110 | ribosome biogenesis (GO:0042254) | 3.17043054 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.15102297 |
| 112 | striated muscle contraction (GO:0006941) | 3.14462026 |
| 113 | establishment of protein localization to mitochondrion (GO:0072655) | 3.14170055 |
| 114 | translational elongation (GO:0006414) | 3.13168895 |
| 115 | cellular component biogenesis (GO:0044085) | 3.12377236 |
| 116 | plasma membrane repair (GO:0001778) | 3.11309487 |
| 117 | proline biosynthetic process (GO:0006561) | 3.10507940 |
| 118 | cell communication by electrical coupling (GO:0010644) | 3.10051717 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.09654633 |
| 120 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.09128967 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 3.08037259 |
| 122 | quaternary ammonium group transport (GO:0015697) | 3.06769864 |
| 123 | DNA unwinding involved in DNA replication (GO:0006268) | 3.06643500 |
| 124 | GDP-mannose metabolic process (GO:0019673) | 3.06107759 |
| 125 | negative regulation of B cell apoptotic process (GO:0002903) | 3.06059652 |
| 126 | translational termination (GO:0006415) | 3.04729926 |
| 127 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.03934950 |
| 128 | cell communication involved in cardiac conduction (GO:0086065) | 3.03567971 |
| 129 | dicarboxylic acid catabolic process (GO:0043649) | 3.01361193 |
| 130 | tRNA aminoacylation for protein translation (GO:0006418) | 3.00148553 |
| 131 | purine nucleobase biosynthetic process (GO:0009113) | 2.99427163 |
| 132 | IMP biosynthetic process (GO:0006188) | 2.98761249 |
| 133 | amino-acid betaine metabolic process (GO:0006577) | 2.97948326 |
| 134 | ribosome assembly (GO:0042255) | 2.97641859 |
| 135 | protein localization to mitochondrion (GO:0070585) | 2.97017306 |
| 136 | regulation of ligase activity (GO:0051340) | 2.96350398 |
| 137 | telomere maintenance via recombination (GO:0000722) | 2.95787420 |
| 138 | regulation of membrane repolarization (GO:0060306) | 2.95723746 |
| 139 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.95075913 |
| 140 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.94010293 |
| 141 | cardiac muscle hypertrophy (GO:0003300) | 2.93868077 |
| 142 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.93815275 |
| 143 | regulation of cellular amine metabolic process (GO:0033238) | 2.93779950 |
| 144 | positive regulation of cell cycle arrest (GO:0071158) | 2.93775122 |
| 145 | hydrogen ion transmembrane transport (GO:1902600) | 2.93752260 |
| 146 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92956386 |
| 147 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.92750866 |
| 148 | viral mRNA export from host cell nucleus (GO:0046784) | 2.91530451 |
| 149 | spliceosomal snRNP assembly (GO:0000387) | 2.91194089 |
| 150 | amino acid activation (GO:0043038) | 2.90890209 |
| 151 | tRNA aminoacylation (GO:0043039) | 2.90890209 |
| 152 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.90376841 |
| 153 | glycogen catabolic process (GO:0005980) | 2.89964551 |
| 154 | fatty acid homeostasis (GO:0055089) | 2.89721000 |
| 155 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.88297128 |
| 156 | monosaccharide biosynthetic process (GO:0046364) | 2.88017115 |
| 157 | ubiquinone metabolic process (GO:0006743) | 2.87417819 |
| 158 | GMP metabolic process (GO:0046037) | 2.86468046 |
| 159 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.85905415 |
| 160 | regulation of cellular respiration (GO:0043457) | 2.85304468 |
| 161 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84945723 |
| 162 | metallo-sulfur cluster assembly (GO:0031163) | 2.84843994 |
| 163 | iron-sulfur cluster assembly (GO:0016226) | 2.84843994 |
| 164 | purine nucleotide salvage (GO:0032261) | 2.84603607 |
| 165 | rRNA processing (GO:0006364) | 2.84456346 |
| 166 | chaperone-mediated protein transport (GO:0072321) | 2.84242594 |
| 167 | actin-mediated cell contraction (GO:0070252) | 2.83966063 |
| 168 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83440884 |
| 169 | glyoxylate metabolic process (GO:0046487) | 2.82316135 |
| 170 | translation (GO:0006412) | 2.82227236 |
| 171 | generation of precursor metabolites and energy (GO:0006091) | 2.82050932 |
| 172 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.81805409 |
| 173 | cotranslational protein targeting to membrane (GO:0006613) | 2.81299168 |
| 174 | striated muscle hypertrophy (GO:0014897) | 2.81232105 |
| 175 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.81007460 |
| 176 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.81007460 |
| 177 | protein targeting to ER (GO:0045047) | 2.80408416 |
| 178 | regulation of striated muscle contraction (GO:0006942) | 2.80333074 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.80155343 |
| 180 | regulation of sarcomere organization (GO:0060297) | 2.79590902 |
| 181 | * NAD metabolic process (GO:0019674) | 2.79560994 |
| 182 | translational initiation (GO:0006413) | 2.78630279 |
| 183 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.78104014 |
| 184 | rRNA modification (GO:0000154) | 2.77200254 |
| 185 | IMP metabolic process (GO:0046040) | 2.76532567 |
| 186 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.75441947 |
| 187 | thioester biosynthetic process (GO:0035384) | 2.73785198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.76447059 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.88178662 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.49198639 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.44179166 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.22562762 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52629855 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.34666742 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.29410074 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.93281004 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.92028242 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.83975707 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.62233555 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50876083 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.44250305 |
| 15 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43908723 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37250082 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.30704599 |
| 18 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.28278460 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.26883255 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.23610237 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18752956 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10554060 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08352506 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.05079021 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00570909 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99596316 |
| 27 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99348141 |
| 28 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.95591432 |
| 29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.94235163 |
| 30 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.93464312 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92124170 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.89080492 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.88791671 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.87579958 |
| 35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.82502616 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80331364 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76362283 |
| 38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74278479 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.74022798 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72821182 |
| 41 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.72362846 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69722865 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.63921882 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61407699 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.60872334 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60732740 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59898174 |
| 48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59426420 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58655219 |
| 50 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56923473 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56876461 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56876461 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55343076 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52990051 |
| 55 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52807057 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50008664 |
| 57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.49302390 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48930028 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46162573 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46002344 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44601932 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44338156 |
| 63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43687601 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42800305 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41562109 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38227580 |
| 67 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36574622 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.36155335 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.35902065 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35722003 |
| 71 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35541343 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32653560 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31495692 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31440032 |
| 75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28598894 |
| 76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28560141 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24936313 |
| 78 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23500219 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22766350 |
| 80 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22555022 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22005330 |
| 82 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21121985 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20884391 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20661279 |
| 85 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19983485 |
| 86 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19463930 |
| 87 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17563118 |
| 88 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17448083 |
| 89 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16782201 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16450486 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16139455 |
| 92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16029551 |
| 93 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15505320 |
| 94 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15434674 |
| 95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14136882 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12056208 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11041337 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10560095 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08650094 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07707006 |
| 101 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06663998 |
| 102 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05676100 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05565217 |
| 104 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05503950 |
| 105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05362973 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05353955 |
| 107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05186447 |
| 108 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04780037 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04337555 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01609717 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01419693 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 1.01151174 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00632389 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99660553 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99083748 |
| 116 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97923482 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97595073 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97282601 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96755505 |
| 120 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96754009 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95835707 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95370184 |
| 123 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94956907 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94908920 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94217122 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94211963 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93975338 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92598805 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 0.92039385 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90764594 |
| 131 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88589483 |
| 132 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88081944 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87567550 |
| 134 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87383829 |
| 135 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84627313 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84619629 |
| 137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83475007 |
| 138 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82220698 |
| 139 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.82175916 |
| 140 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82066529 |
| 141 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81090796 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81056071 |
| 143 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80816922 |
| 144 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.80609601 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80557912 |
| 146 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79176200 |
| 147 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.79006224 |
| 148 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78531221 |
| 149 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.77890301 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76607960 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75106692 |
| 152 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74253907 |
| 153 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.73656920 |
| 154 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.73656920 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72549589 |
| 156 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71752911 |
| 157 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71374502 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70908692 |
| 159 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.70498289 |
| 160 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69847010 |
| 161 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.69740923 |
| 162 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69457975 |
| 163 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.69268627 |
| 164 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.68853755 |
| 165 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.68413847 |
| 166 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.68409026 |
| 167 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.68409026 |
| 168 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.68194308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.48045571 |
| 2 | MP0003646_muscle_fatigue | 5.19520261 |
| 3 | MP0000751_myopathy | 4.07161347 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.88302896 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.63034282 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.51468824 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.51363837 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.51151518 |
| 9 | MP0008058_abnormal_DNA_repair | 3.38964167 |
| 10 | MP0005451_abnormal_body_composition | 3.20716205 |
| 11 | MP0004130_abnormal_muscle_cell | 3.19010826 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.15830566 |
| 13 | MP0000749_muscle_degeneration | 2.95363314 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.94760565 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.89071063 |
| 16 | MP0005330_cardiomyopathy | 2.86730584 |
| 17 | MP0003077_abnormal_cell_cycle | 2.66864158 |
| 18 | MP0003786_premature_aging | 2.64486484 |
| 19 | MP0005360_urolithiasis | 2.39615879 |
| 20 | MP0000372_irregular_coat_pigmentation | 2.30452116 |
| 21 | MP0008932_abnormal_embryonic_tissue | 2.29162672 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.29058328 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.27613710 |
| 24 | MP0008260_abnormal_autophagy | 2.27444281 |
| 25 | MP0008007_abnormal_cellular_replicative | 2.23505472 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.22579517 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 2.13721599 |
| 28 | MP0004087_abnormal_muscle_fiber | 2.13134799 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 2.11691005 |
| 30 | MP0002972_abnormal_cardiac_muscle | 2.09203220 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 2.07038066 |
| 32 | MP0005620_abnormal_muscle_contractility | 2.05255408 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 2.05225108 |
| 34 | MP0005670_abnormal_white_adipose | 2.03021094 |
| 35 | MP0004484_altered_response_of | 1.99417507 |
| 36 | MP0001853_heart_inflammation | 1.99178857 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.98394254 |
| 38 | MP0002269_muscular_atrophy | 1.98093666 |
| 39 | MP0005365_abnormal_bile_salt | 1.90177068 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.88737989 |
| 41 | MP0000747_muscle_weakness | 1.88380161 |
| 42 | MP0002106_abnormal_muscle_physiology | 1.88188322 |
| 43 | MP0004859_abnormal_synaptic_plasticity | 1.87554854 |
| 44 | MP0001727_abnormal_embryo_implantation | 1.84850023 |
| 45 | MP0003186_abnormal_redox_activity | 1.82951984 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.82249562 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.82249562 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.80535230 |
| 49 | MP0000358_abnormal_cell_content/ | 1.78286337 |
| 50 | MP0005332_abnormal_amino_acid | 1.76423013 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.71424935 |
| 52 | MP0002822_catalepsy | 1.70941352 |
| 53 | MP0006138_congestive_heart_failure | 1.68858410 |
| 54 | MP0001730_embryonic_growth_arrest | 1.67035131 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.66670178 |
| 56 | MP0001661_extended_life_span | 1.65864679 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.60623862 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60056194 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.59011063 |
| 60 | MP0004233_abnormal_muscle_weight | 1.58807289 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.58720388 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.57405080 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.54741951 |
| 64 | MP0004085_abnormal_heartbeat | 1.53996630 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.51750581 |
| 66 | MP0005369_muscle_phenotype | 1.48051171 |
| 67 | MP0004043_abnormal_pH_regulation | 1.47981753 |
| 68 | MP0005535_abnormal_body_temperature | 1.46349426 |
| 69 | MP0010630_abnormal_cardiac_muscle | 1.45486364 |
| 70 | MP0000313_abnormal_cell_death | 1.44365783 |
| 71 | MP0003880_abnormal_central_pattern | 1.42246419 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41954140 |
| 73 | MP0001873_stomach_inflammation | 1.39067724 |
| 74 | MP0004147_increased_porphyrin_level | 1.36648397 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.33709788 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 1.31213839 |
| 77 | MP0009046_muscle_twitch | 1.29406959 |
| 78 | MP0002971_abnormal_brown_adipose | 1.28732178 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.28212744 |
| 80 | MP0003195_calcinosis | 1.27194513 |
| 81 | MP0005266_abnormal_metabolism | 1.23522301 |
| 82 | MP0008995_early_reproductive_senescence | 1.23257887 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.23073050 |
| 84 | MP0002398_abnormal_bone_marrow | 1.22997819 |
| 85 | MP0002722_abnormal_immune_system | 1.22131701 |
| 86 | MP0009697_abnormal_copulation | 1.21475914 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 1.21150300 |
| 88 | MP0000703_abnormal_thymus_morphology | 1.19917065 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 1.18383182 |
| 90 | MP0009745_abnormal_behavioral_response | 1.18349256 |
| 91 | MP0002909_abnormal_adrenal_gland | 1.17294505 |
| 92 | MP0005464_abnormal_platelet_physiology | 1.17290168 |
| 93 | MP0002396_abnormal_hematopoietic_system | 1.16315502 |
| 94 | MP0002132_abnormal_respiratory_system | 1.15081535 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.12917751 |
| 96 | MP0002429_abnormal_blood_cell | 1.12711196 |
| 97 | MP0005083_abnormal_biliary_tract | 1.12478796 |
| 98 | MP0000689_abnormal_spleen_morphology | 1.12226781 |
| 99 | MP0002080_prenatal_lethality | 1.11843224 |
| 100 | MP0003718_maternal_effect | 1.11446672 |
| 101 | MP0000015_abnormal_ear_pigmentation | 1.11052903 |
| 102 | MP0006082_CNS_inflammation | 1.10900864 |
| 103 | MP0002064_seizures | 1.08348328 |
| 104 | MP0000858_altered_metastatic_potential | 1.06183476 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 1.02412825 |
| 106 | MP0001545_abnormal_hematopoietic_system | 1.02242569 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 1.02242569 |
| 108 | MP0009840_abnormal_foam_cell | 1.00600014 |
| 109 | MP0000230_abnormal_systemic_arterial | 1.00376285 |
| 110 | MP0002272_abnormal_nervous_system | 0.99683292 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.99281867 |
| 112 | MP0000490_abnormal_crypts_of | 0.99030450 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.96364354 |
| 114 | MP0004924_abnormal_behavior | 0.96364354 |
| 115 | MP0000716_abnormal_immune_system | 0.95764191 |
| 116 | MP0009278_abnormal_bone_marrow | 0.94747349 |
| 117 | MP0003329_amyloid_beta_deposits | 0.92908919 |
| 118 | MP0002736_abnormal_nociception_after | 0.92714002 |
| 119 | MP0002063_abnormal_learning/memory/cond | 0.92352788 |
| 120 | MP0003252_abnormal_bile_duct | 0.91145529 |
| 121 | MP0002127_abnormal_cardiovascular_syste | 0.90589083 |
| 122 | MP0004510_myositis | 0.90166555 |
| 123 | MP0005501_abnormal_skin_physiology | 0.89254277 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.89096817 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.88887376 |
| 126 | MP0002420_abnormal_adaptive_immunity | 0.88555736 |
| 127 | MP0003828_pulmonary_edema | 0.87477984 |
| 128 | MP0005408_hypopigmentation | 0.86866462 |
| 129 | MP0001819_abnormal_immune_cell | 0.86473786 |
| 130 | MP0008872_abnormal_physiological_respon | 0.86409582 |
| 131 | MP0005671_abnormal_response_to | 0.85515311 |
| 132 | MP0001529_abnormal_vocalization | 0.82811273 |
| 133 | MP0004142_abnormal_muscle_tone | 0.82169289 |
| 134 | MP0005025_abnormal_response_to | 0.81693343 |
| 135 | MP0005384_cellular_phenotype | 0.80860314 |
| 136 | MP0003436_decreased_susceptibility_to | 0.80704073 |
| 137 | MP0001764_abnormal_homeostasis | 0.79617827 |
| 138 | MP0002723_abnormal_immune_serum | 0.78916606 |
| 139 | MP0005165_increased_susceptibility_to | 0.78417685 |
| 140 | MP0001440_abnormal_grooming_behavior | 0.77737418 |
| 141 | MP0002452_abnormal_antigen_presenting | 0.77683861 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.77029903 |
| 143 | MP0000609_abnormal_liver_physiology | 0.76825614 |
| 144 | MP0001835_abnormal_antigen_presentation | 0.76348521 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.75764216 |
| 146 | MP0005000_abnormal_immune_tolerance | 0.75662973 |
| 147 | MP0002572_abnormal_emotion/affect_behav | 0.75562997 |
| 148 | MP0003315_abnormal_perineum_morphology | 0.75525558 |
| 149 | MP0005636_abnormal_mineral_homeostasis | 0.75415973 |
| 150 | MP0008569_lethality_at_weaning | 0.74650143 |
| 151 | MP0002067_abnormal_sensory_capabilities | 0.74453446 |
| 152 | MP0001765_abnormal_ion_homeostasis | 0.73791123 |
| 153 | MP0001800_abnormal_humoral_immune | 0.73534841 |
| 154 | MP0000343_altered_response_to | 0.73163166 |
| 155 | MP0004270_analgesia | 0.72980524 |
| 156 | MP0008469_abnormal_protein_level | 0.71968689 |
| 157 | MP0001697_abnormal_embryo_size | 0.71559230 |
| 158 | MP0001905_abnormal_dopamine_level | 0.70889426 |
| 159 | MP0005448_abnormal_energy_balance | 0.70797068 |
| 160 | MP0001501_abnormal_sleep_pattern | 0.70779033 |
| 161 | MP0009763_increased_sensitivity_to | 0.70454680 |
| 162 | MP0008874_decreased_physiological_sensi | 0.70393277 |
| 163 | MP0005334_abnormal_fat_pad | 0.69789593 |
| 164 | MP0002148_abnormal_hypersensitivity_rea | 0.69450907 |
| 165 | MP0005376_homeostasis/metabolism_phenot | 0.69045969 |
| 166 | MP0003879_abnormal_hair_cell | 0.68967784 |
| 167 | MP0005380_embryogenesis_phenotype | 0.68405493 |
| 168 | MP0001672_abnormal_embryogenesis/_devel | 0.68405493 |
| 169 | MP0004185_abnormal_adipocyte_glucose | 0.65620869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.85380979 |
| 2 | Myoglobinuria (HP:0002913) | 4.75807170 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.65821748 |
| 4 | Hepatic necrosis (HP:0002605) | 4.62587195 |
| 5 | Sudden death (HP:0001699) | 4.59948725 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 4.51069853 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 4.44383968 |
| 8 | Acute encephalopathy (HP:0006846) | 4.30166183 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.26725608 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.19490474 |
| 11 | Cholecystitis (HP:0001082) | 4.08914127 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.87699424 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.86708186 |
| 14 | Cerebral edema (HP:0002181) | 3.86128959 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.79841830 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.78519516 |
| 17 | Increased CSF lactate (HP:0002490) | 3.77834511 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.69996720 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.68136650 |
| 20 | Palpitations (HP:0001962) | 3.65449110 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.61177503 |
| 22 | Ketoacidosis (HP:0001993) | 3.59976954 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56023322 |
| 24 | Lactic acidosis (HP:0003128) | 3.50154729 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.48232942 |
| 26 | Dicarboxylic aciduria (HP:0003215) | 3.48232942 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.42874308 |
| 28 | Ventricular tachycardia (HP:0004756) | 3.40990542 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.36060144 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 3.36060144 |
| 31 | Hyperalaninemia (HP:0003348) | 3.36060144 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 3.32514591 |
| 33 | Increased serum pyruvate (HP:0003542) | 3.31665703 |
| 34 | Abnormality of glycolysis (HP:0004366) | 3.31665703 |
| 35 | Ketosis (HP:0001946) | 3.31468527 |
| 36 | Hyperglycinuria (HP:0003108) | 3.25400052 |
| 37 | Hyperammonemia (HP:0001987) | 3.17727373 |
| 38 | Ragged-red muscle fibers (HP:0003200) | 3.10631741 |
| 39 | Atrial fibrillation (HP:0005110) | 3.04073813 |
| 40 | Pheochromocytoma (HP:0002666) | 3.01049660 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00822999 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00822999 |
| 43 | Reticulocytopenia (HP:0001896) | 2.99287968 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 2.99215026 |
| 45 | Myopathic facies (HP:0002058) | 2.98855018 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.97105648 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.96432540 |
| 48 | Nemaline bodies (HP:0003798) | 2.89598599 |
| 49 | Myotonia (HP:0002486) | 2.89250179 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.88577698 |
| 51 | Exercise intolerance (HP:0003546) | 2.85777929 |
| 52 | Primary atrial arrhythmia (HP:0001692) | 2.85592334 |
| 53 | Syncope (HP:0001279) | 2.85464143 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.83520118 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83520118 |
| 56 | Supraventricular tachycardia (HP:0004755) | 2.83193686 |
| 57 | Respiratory failure (HP:0002878) | 2.82432680 |
| 58 | Lethargy (HP:0001254) | 2.82373832 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.82225591 |
| 60 | Lipoatrophy (HP:0100578) | 2.81086880 |
| 61 | Muscle stiffness (HP:0003552) | 2.78276644 |
| 62 | Supraventricular arrhythmia (HP:0005115) | 2.75537373 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.75452224 |
| 64 | Round ear (HP:0100830) | 2.71983865 |
| 65 | Type I transferrin isoform profile (HP:0003642) | 2.71777521 |
| 66 | Bundle branch block (HP:0011710) | 2.70435971 |
| 67 | Increased serum lactate (HP:0002151) | 2.61363790 |
| 68 | Conjunctival hamartoma (HP:0100780) | 2.60838975 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.60833928 |
| 70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.59979945 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.59009975 |
| 72 | Metabolic acidosis (HP:0001942) | 2.58381353 |
| 73 | Neoplasm of head and neck (HP:0012288) | 2.55146587 |
| 74 | Esophageal neoplasm (HP:0100751) | 2.55146587 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53680941 |
| 76 | Dilated cardiomyopathy (HP:0001644) | 2.52609901 |
| 77 | EMG: myopathic abnormalities (HP:0003458) | 2.52213863 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.49542369 |
| 79 | Hyporeflexia of lower limbs (HP:0002600) | 2.48805484 |
| 80 | Testicular atrophy (HP:0000029) | 2.47923740 |
| 81 | Hyperglycinemia (HP:0002154) | 2.44155629 |
| 82 | Vomiting (HP:0002013) | 2.39843946 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.38009823 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.37509064 |
| 85 | Abnormality of the anterior horn cell (HP:0006802) | 2.36745161 |
| 86 | Degeneration of anterior horn cells (HP:0002398) | 2.36745161 |
| 87 | Abnormal number of erythroid precursors (HP:0012131) | 2.36342559 |
| 88 | Prolonged QT interval (HP:0001657) | 2.36020825 |
| 89 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.35648907 |
| 90 | Subaortic stenosis (HP:0001682) | 2.35648907 |
| 91 | Atrioventricular block (HP:0001678) | 2.35348209 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.34712415 |
| 93 | Difficulty running (HP:0009046) | 2.34602015 |
| 94 | Heart block (HP:0012722) | 2.34326045 |
| 95 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.32921361 |
| 96 | Gout (HP:0001997) | 2.31654131 |
| 97 | CNS demyelination (HP:0007305) | 2.30658165 |
| 98 | Progressive external ophthalmoplegia (HP:0000590) | 2.30266185 |
| 99 | Focal motor seizures (HP:0011153) | 2.27533071 |
| 100 | Aplastic anemia (HP:0001915) | 2.26281022 |
| 101 | Dysmetric saccades (HP:0000641) | 2.23582843 |
| 102 | Athetosis (HP:0002305) | 2.22904439 |
| 103 | Rough bone trabeculation (HP:0100670) | 2.22257392 |
| 104 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.21905027 |
| 105 | Multiple enchondromatosis (HP:0005701) | 2.20542829 |
| 106 | Seborrheic dermatitis (HP:0001051) | 2.19470712 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.19027876 |
| 108 | Increased connective tissue (HP:0009025) | 2.15055336 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.12645946 |
| 110 | Cholelithiasis (HP:0001081) | 2.11270598 |
| 111 | Neoplasm of the adrenal gland (HP:0100631) | 2.10773893 |
| 112 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10500185 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 2.09542401 |
| 114 | Muscle fiber inclusion bodies (HP:0100299) | 2.09204267 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.09024900 |
| 116 | Respiratory difficulties (HP:0002880) | 2.08883222 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.08497947 |
| 118 | Oligomenorrhea (HP:0000876) | 2.07275485 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.06424581 |
| 120 | Abnormal protein glycosylation (HP:0012346) | 2.06205994 |
| 121 | Abnormal glycosylation (HP:0012345) | 2.06205994 |
| 122 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06205994 |
| 123 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06205994 |
| 124 | Nausea (HP:0002018) | 2.05521569 |
| 125 | Hypertensive crisis (HP:0100735) | 2.01454731 |
| 126 | Emotional lability (HP:0000712) | 2.01188184 |
| 127 | Abnormality of reticulocytes (HP:0004312) | 1.99965952 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.99444464 |
| 129 | Pancytopenia (HP:0001876) | 1.99293376 |
| 130 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.98745206 |
| 131 | * Optic disc pallor (HP:0000543) | 1.97936851 |
| 132 | Tinnitus (HP:0000360) | 1.97040737 |
| 133 | Cerebral palsy (HP:0100021) | 1.96519641 |
| 134 | Leukodystrophy (HP:0002415) | 1.96390427 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 1.95312414 |
| 136 | Secondary amenorrhea (HP:0000869) | 1.87107626 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 1.86499754 |
| 138 | Spastic paraparesis (HP:0002313) | 1.85915268 |
| 139 | Renal Fanconi syndrome (HP:0001994) | 1.84237029 |
| 140 | IgM deficiency (HP:0002850) | 1.83766610 |
| 141 | Premature ovarian failure (HP:0008209) | 1.83049419 |
| 142 | Epiphyseal stippling (HP:0010655) | 1.77984635 |
| 143 | Trismus (HP:0000211) | 1.77730466 |
| 144 | Vertebral compression fractures (HP:0002953) | 1.77351422 |
| 145 | Muscle fiber atrophy (HP:0100295) | 1.75627632 |
| 146 | Amniotic constriction ring (HP:0009775) | 1.75598046 |
| 147 | Abnormality of placental membranes (HP:0011409) | 1.75598046 |
| 148 | Macrocytic anemia (HP:0001972) | 1.75342831 |
| 149 | Distal lower limb muscle weakness (HP:0009053) | 1.72099731 |
| 150 | Granulocytopenia (HP:0001913) | 1.71553709 |
| 151 | Toxemia of pregnancy (HP:0100603) | 1.71393111 |
| 152 | Opisthotonus (HP:0002179) | 1.70665967 |
| 153 | Agammaglobulinemia (HP:0004432) | 1.69587405 |
| 154 | Cupped ribs (HP:0000887) | 1.68085574 |
| 155 | Obstructive lung disease (HP:0006536) | 1.67943476 |
| 156 | Chronic obstructive pulmonary disease (HP:0006510) | 1.67943476 |
| 157 | CNS hypomyelination (HP:0003429) | 1.65962735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK3 | 4.46507853 |
| 2 | PDK4 | 4.46507853 |
| 3 | VRK2 | 4.43875222 |
| 4 | BCKDK | 4.34206202 |
| 5 | BUB1 | 3.59103676 |
| 6 | TESK2 | 3.34740680 |
| 7 | TTN | 3.33792936 |
| 8 | NEK1 | 3.24974014 |
| 9 | OBSCN | 3.22075900 |
| 10 | PHKG2 | 2.97245135 |
| 11 | PHKG1 | 2.97245135 |
| 12 | LMTK2 | 2.91049084 |
| 13 | MYLK | 2.79557069 |
| 14 | PDK2 | 2.65574067 |
| 15 | PINK1 | 2.50330958 |
| 16 | SRPK1 | 2.45721543 |
| 17 | MAP3K12 | 2.36848769 |
| 18 | TRIB3 | 2.27396845 |
| 19 | PBK | 2.26891642 |
| 20 | PKN2 | 2.24445806 |
| 21 | MAP2K4 | 2.06608473 |
| 22 | SMG1 | 2.06576484 |
| 23 | PIM2 | 1.95715964 |
| 24 | TESK1 | 1.91168626 |
| 25 | CDC7 | 1.88951680 |
| 26 | NME1 | 1.83623421 |
| 27 | MAP3K4 | 1.81167940 |
| 28 | NTRK3 | 1.72340022 |
| 29 | MUSK | 1.71609556 |
| 30 | TIE1 | 1.69215602 |
| 31 | SCYL2 | 1.62552869 |
| 32 | EIF2AK1 | 1.51911760 |
| 33 | EPHA4 | 1.50897341 |
| 34 | LIMK1 | 1.49783480 |
| 35 | IRAK3 | 1.49377489 |
| 36 | MAP2K7 | 1.44171801 |
| 37 | KIT | 1.39715972 |
| 38 | VRK1 | 1.33257694 |
| 39 | MAP4K1 | 1.29387122 |
| 40 | NME2 | 1.23762808 |
| 41 | ARAF | 1.21395607 |
| 42 | DAPK1 | 1.17012953 |
| 43 | FLT3 | 1.16265377 |
| 44 | CDK19 | 1.15169316 |
| 45 | FES | 1.12602640 |
| 46 | DAPK2 | 1.12334868 |
| 47 | MAPK12 | 1.10826555 |
| 48 | ERN1 | 1.10199654 |
| 49 | MAP3K9 | 1.09797987 |
| 50 | MAP3K7 | 1.08702642 |
| 51 | AURKA | 1.08466989 |
| 52 | GRK7 | 1.07895214 |
| 53 | MAP2K3 | 1.07376097 |
| 54 | MINK1 | 1.06964341 |
| 55 | CSNK1G3 | 1.06526198 |
| 56 | EPHA2 | 1.05123373 |
| 57 | PAK4 | 1.04663004 |
| 58 | PIK3CA | 0.98269882 |
| 59 | ATR | 0.96861428 |
| 60 | DAPK3 | 0.92948729 |
| 61 | LRRK2 | 0.92462462 |
| 62 | KSR2 | 0.91341296 |
| 63 | STK38 | 0.90966860 |
| 64 | GRK5 | 0.88662660 |
| 65 | TTK | 0.86748705 |
| 66 | ZAK | 0.85003122 |
| 67 | CAMK1 | 0.84806056 |
| 68 | CAMK2D | 0.83394467 |
| 69 | AURKB | 0.82802199 |
| 70 | MAP2K6 | 0.82744664 |
| 71 | CAMKK2 | 0.81765969 |
| 72 | CSNK1A1L | 0.81178179 |
| 73 | WNK4 | 0.81170189 |
| 74 | BRSK1 | 0.79528725 |
| 75 | PLK1 | 0.77043152 |
| 76 | CDK8 | 0.76581855 |
| 77 | ILK | 0.75239146 |
| 78 | MAP3K11 | 0.74246494 |
| 79 | PAK1 | 0.73255644 |
| 80 | RPS6KA4 | 0.73100415 |
| 81 | MAP3K5 | 0.73070694 |
| 82 | RPS6KA5 | 0.71183389 |
| 83 | PTK2B | 0.70289713 |
| 84 | CAMK2A | 0.69649849 |
| 85 | BRAF | 0.69620807 |
| 86 | MST1R | 0.69420806 |
| 87 | CDK7 | 0.68883706 |
| 88 | PDPK1 | 0.68091082 |
| 89 | CHEK2 | 0.67915883 |
| 90 | CDK4 | 0.67793479 |
| 91 | PDK1 | 0.67479067 |
| 92 | KDR | 0.66754452 |
| 93 | TBK1 | 0.66375780 |
| 94 | PAK3 | 0.65433204 |
| 95 | CAMK2G | 0.65364873 |
| 96 | PRKAA1 | 0.65025698 |
| 97 | MST4 | 0.64516399 |
| 98 | PRKAA2 | 0.63701336 |
| 99 | MAP3K8 | 0.62311861 |
| 100 | IKBKB | 0.61102119 |
| 101 | MAP4K2 | 0.61086766 |
| 102 | CDK11A | 0.60969023 |
| 103 | CDK14 | 0.60557490 |
| 104 | CAMKK1 | 0.58504108 |
| 105 | PRKCG | 0.58095972 |
| 106 | PAK6 | 0.57802200 |
| 107 | MAPKAPK5 | 0.56705565 |
| 108 | CSNK1G1 | 0.56061647 |
| 109 | MAP2K1 | 0.54594467 |
| 110 | MAPKAPK3 | 0.54074415 |
| 111 | CDK15 | 0.54004593 |
| 112 | STK24 | 0.53060576 |
| 113 | CDK18 | 0.52110324 |
| 114 | CSNK2A2 | 0.51989997 |
| 115 | CHEK1 | 0.51798200 |
| 116 | PRKACG | 0.51654567 |
| 117 | RPS6KB2 | 0.51437420 |
| 118 | CSNK2A1 | 0.50953549 |
| 119 | INSRR | 0.50689760 |
| 120 | TLK1 | 0.50596534 |
| 121 | CCNB1 | 0.50343054 |
| 122 | ALK | 0.49756829 |
| 123 | PRKACA | 0.49706015 |
| 124 | CAMK4 | 0.49642763 |
| 125 | STK10 | 0.48613550 |
| 126 | DMPK | 0.48562415 |
| 127 | EIF2AK3 | 0.48095099 |
| 128 | MAP3K13 | 0.48035875 |
| 129 | SYK | 0.47142551 |
| 130 | ICK | 0.46625019 |
| 131 | CDK9 | 0.46288591 |
| 132 | MAPK11 | 0.45730834 |
| 133 | PLK2 | 0.44333236 |
| 134 | CSNK1G2 | 0.43934266 |
| 135 | PRKD1 | 0.42852047 |
| 136 | TAOK2 | 0.41446032 |
| 137 | GRK6 | 0.38774802 |
| 138 | PRKACB | 0.38719573 |
| 139 | RIPK4 | 0.38130101 |
| 140 | CDK5 | 0.37639226 |
| 141 | AKT2 | 0.37252115 |
| 142 | WNK3 | 0.37242433 |
| 143 | RAF1 | 0.35634518 |
| 144 | SIK1 | 0.35532280 |
| 145 | RET | 0.33824007 |
| 146 | PRKCI | 0.33173137 |
| 147 | CAMK2B | 0.32964497 |
| 148 | CDK2 | 0.32675403 |
| 149 | PLK3 | 0.31662156 |
| 150 | SIK3 | 0.31644579 |
| 151 | KSR1 | 0.30624034 |
| 152 | TSSK6 | 0.30565936 |
| 153 | OXSR1 | 0.30089728 |
| 154 | STK4 | 0.29936061 |
| 155 | MAP3K1 | 0.29328753 |
| 156 | STK16 | 0.29318914 |
| 157 | ROCK1 | 0.28108506 |
| 158 | TNIK | 0.27910416 |
| 159 | PRKCH | 0.27661892 |
| 160 | CASK | 0.27480866 |
| 161 | WEE1 | 0.26884374 |
| 162 | ATM | 0.26847973 |
| 163 | PRKCE | 0.26354454 |
| 164 | PRKG2 | 0.26177890 |
| 165 | ADRBK1 | 0.25788241 |
| 166 | SGK3 | 0.25067257 |
| 167 | MAPK4 | 0.25066669 |
| 168 | RPS6KA3 | 0.25018993 |
| 169 | ABL2 | 0.24065618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.52757479 |
| 2 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.94959664 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.74018961 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.55314872 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51111294 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27412776 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.10483641 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 3.04852939 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 3.00872995 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96655799 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78484438 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.71066658 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64831689 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.62278901 |
| 15 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.53728551 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.51683631 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.35320661 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.30159169 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 2.22495380 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21975477 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 2.16429233 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08756499 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00077285 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92283572 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.89756895 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80151720 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.65716354 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.57859653 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.56971724 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51826835 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50866884 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50540127 |
| 33 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47928960 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44676196 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43818845 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36608425 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36356419 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35698824 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31550390 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 1.30964153 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.28564212 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24124230 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23940350 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20676168 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19698185 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.19635881 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17631883 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 1.11640275 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09577113 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09197732 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07593645 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.06422520 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05092518 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04599466 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.97740485 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.97233639 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97041078 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93857381 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92812644 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91491907 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90852420 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89997453 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89801708 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84661875 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84023830 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83673313 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83561167 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81218426 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74236419 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73420735 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73086077 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.72767492 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72262659 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70001563 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69992566 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69280720 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66103726 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65360754 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63125617 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62586237 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62014740 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.60520589 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60456322 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60446676 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60337911 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59857029 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58911128 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58413367 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57240584 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56891707 |
| 91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54828530 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53676612 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53035823 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52950026 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50018708 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49614675 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.49394452 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.49264289 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49063016 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48664156 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.47670830 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47236774 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.45616383 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.44576352 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44512494 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.44163606 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.43654455 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43468699 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43420396 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42819869 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42072996 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.40282440 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40048420 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39420732 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38581899 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38228832 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.38199380 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37521338 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36285486 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36247388 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36117558 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36003989 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.35974743 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35394230 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34648739 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34341425 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34096445 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33511882 |
| 129 | Allograft rejection_Homo sapiens_hsa05330 | 0.33002676 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32246862 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31362519 |
| 132 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30266655 |
| 133 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30037894 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29180316 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27871557 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23791231 |
| 137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21228487 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20577713 |
| 139 | Protein export_Homo sapiens_hsa03060 | 0.20235308 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19959777 |
| 141 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18924525 |
| 142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18806206 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17702655 |
| 144 | Apoptosis_Homo sapiens_hsa04210 | 0.17079866 |
| 145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16659873 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.16537826 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16308641 |
| 148 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.15808988 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.14854221 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.14639907 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.14504317 |
| 152 | Asthma_Homo sapiens_hsa05310 | 0.14276364 |
| 153 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.14033037 |
| 154 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.11471907 |

